Lassen Therapeutics is a biotechnology research company based in San Diego, California, focused on developing novel, best-in-class biotherapeutics to treat patients with serious diseases.
Subscribe to see Lassen Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Lassen Therapeutics is a biotechnology company headquartered in United States. It has raised at least $85M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Series B, raised $85M in December 2023. Xcout tracks 11 named people at Lassen Therapeutics, including Maria Fardis (Chief Executive Officer).
5 more named people on record for Lassen Therapeutics, with roles, board committees and tenure — see the full roster →
At least $85M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $85M | 7 named | |
| — | Undisclosed | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Lassen Therapeutics's closest competitors — see the full list of competitors and alternatives →
Autobahn Therapeutics, Inc. is a privately held biopharmaceutical company with its corporate office and headquarters located in San Diego, California, focused on restoring hope for patients.
Crystalys Therapeutics is a biotechnology research company headquartered in San Diego, California, dedicated to developing novel therapies to address significant unmet medical needs.
Cellics Therapeutics, Inc. is a privately held biotechnology company headquartered in San Diego, California, developing novel therapeutic products.
Autobahn Therapeutics is a biotechnology company headquartered in San Diego, California, focused on developing restorative treatments in the medical sector.
cAMPfield Therapeutics is a biotechnology research company headquartered in San Diego, California. The company focuses on discovering and developing innovative therapeutic treatments targeting specific biological pathways.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.